Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6.

Standard

Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6. / Poët, Mallorie; Kornak, Uwe; Schweizer, Michaela; Zdebik, Anselm A; Scheel, Olaf; Hoelter, Sabine; Wurst, Wolfgang; Schmitt, Anja; Fuhrmann, Jens C; Planells-Cases, Rosa; Mole, Sara E; Hübner, Christian; Jentsch, Thomas J.

in: P NATL ACAD SCI USA, Jahrgang 103, Nr. 37, 37, 2006, S. 13854-13859.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Poët, M, Kornak, U, Schweizer, M, Zdebik, AA, Scheel, O, Hoelter, S, Wurst, W, Schmitt, A, Fuhrmann, JC, Planells-Cases, R, Mole, SE, Hübner, C & Jentsch, TJ 2006, 'Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6.', P NATL ACAD SCI USA, Jg. 103, Nr. 37, 37, S. 13854-13859. <http://www.ncbi.nlm.nih.gov/pubmed/16950870?dopt=Citation>

APA

Poët, M., Kornak, U., Schweizer, M., Zdebik, A. A., Scheel, O., Hoelter, S., Wurst, W., Schmitt, A., Fuhrmann, J. C., Planells-Cases, R., Mole, S. E., Hübner, C., & Jentsch, T. J. (2006). Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6. P NATL ACAD SCI USA, 103(37), 13854-13859. [37]. http://www.ncbi.nlm.nih.gov/pubmed/16950870?dopt=Citation

Vancouver

Poët M, Kornak U, Schweizer M, Zdebik AA, Scheel O, Hoelter S et al. Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6. P NATL ACAD SCI USA. 2006;103(37):13854-13859. 37.

Bibtex

@article{8bc5e0ba53a7439c8bc2fd4049112395,
title = "Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6.",
abstract = "Mammalian CLC proteins function as Cl(-) channels or as electrogenic Cl(-)/H(+) exchangers and are present in the plasma membrane and intracellular vesicles. We now show that the ClC-6 protein is almost exclusively expressed in neurons of the central and peripheral nervous systems, with a particularly high expression in dorsal root ganglia. ClC-6 colocalized with markers for late endosomes in neuronal cell bodies. The disruption of ClC-6 in mice reduced their pain sensitivity and caused moderate behavioral abnormalities. Neuronal tissues showed autofluorescence at initial axon segments. At these sites, electron microscopy revealed electron-dense storage material that caused a pathological enlargement of proximal axons. These deposits were positive for several lysosomal proteins and other marker proteins typical for neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disease. However, the lysosomal pH of Clcn6(-/-) neurons appeared normal. CLCN6 is a candidate gene for mild forms of human NCL. Analysis of 75 NCL patients identified ClC-6 amino acid exchanges in two patients but failed to prove a causative role of CLCN6 in that disease.",
author = "Mallorie Po{\"e}t and Uwe Kornak and Michaela Schweizer and Zdebik, {Anselm A} and Olaf Scheel and Sabine Hoelter and Wolfgang Wurst and Anja Schmitt and Fuhrmann, {Jens C} and Rosa Planells-Cases and Mole, {Sara E} and Christian H{\"u}bner and Jentsch, {Thomas J}",
year = "2006",
language = "Deutsch",
volume = "103",
pages = "13854--13859",
journal = "P NATL ACAD SCI USA",
issn = "0027-8424",
publisher = "National Academy of Sciences",
number = "37",

}

RIS

TY - JOUR

T1 - Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6.

AU - Poët, Mallorie

AU - Kornak, Uwe

AU - Schweizer, Michaela

AU - Zdebik, Anselm A

AU - Scheel, Olaf

AU - Hoelter, Sabine

AU - Wurst, Wolfgang

AU - Schmitt, Anja

AU - Fuhrmann, Jens C

AU - Planells-Cases, Rosa

AU - Mole, Sara E

AU - Hübner, Christian

AU - Jentsch, Thomas J

PY - 2006

Y1 - 2006

N2 - Mammalian CLC proteins function as Cl(-) channels or as electrogenic Cl(-)/H(+) exchangers and are present in the plasma membrane and intracellular vesicles. We now show that the ClC-6 protein is almost exclusively expressed in neurons of the central and peripheral nervous systems, with a particularly high expression in dorsal root ganglia. ClC-6 colocalized with markers for late endosomes in neuronal cell bodies. The disruption of ClC-6 in mice reduced their pain sensitivity and caused moderate behavioral abnormalities. Neuronal tissues showed autofluorescence at initial axon segments. At these sites, electron microscopy revealed electron-dense storage material that caused a pathological enlargement of proximal axons. These deposits were positive for several lysosomal proteins and other marker proteins typical for neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disease. However, the lysosomal pH of Clcn6(-/-) neurons appeared normal. CLCN6 is a candidate gene for mild forms of human NCL. Analysis of 75 NCL patients identified ClC-6 amino acid exchanges in two patients but failed to prove a causative role of CLCN6 in that disease.

AB - Mammalian CLC proteins function as Cl(-) channels or as electrogenic Cl(-)/H(+) exchangers and are present in the plasma membrane and intracellular vesicles. We now show that the ClC-6 protein is almost exclusively expressed in neurons of the central and peripheral nervous systems, with a particularly high expression in dorsal root ganglia. ClC-6 colocalized with markers for late endosomes in neuronal cell bodies. The disruption of ClC-6 in mice reduced their pain sensitivity and caused moderate behavioral abnormalities. Neuronal tissues showed autofluorescence at initial axon segments. At these sites, electron microscopy revealed electron-dense storage material that caused a pathological enlargement of proximal axons. These deposits were positive for several lysosomal proteins and other marker proteins typical for neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disease. However, the lysosomal pH of Clcn6(-/-) neurons appeared normal. CLCN6 is a candidate gene for mild forms of human NCL. Analysis of 75 NCL patients identified ClC-6 amino acid exchanges in two patients but failed to prove a causative role of CLCN6 in that disease.

M3 - SCORING: Zeitschriftenaufsatz

VL - 103

SP - 13854

EP - 13859

JO - P NATL ACAD SCI USA

JF - P NATL ACAD SCI USA

SN - 0027-8424

IS - 37

M1 - 37

ER -